Optogenetics, a groundbreaking technology that enables scientists to control brain neurons using light, has been awarded the 2026 Nobel Prize in Physiology or Medicine. This technique, developed by Karl Deisseroth, Peter Hegemann, and Georg Nagel, has revolutionized neuroscience by allowing precise control over neuron activity, thus transforming the study of brain function and behavior. The discovery of channelrhodopsin, a light-sensitive protein, was pivotal in this advancement, leading to significant insights into brain disorders like depression and Alzheimer’s. Optogenetics also shows promise in treating blindness, specifically retinitis pigmentosa. The Nobel Committee praised the technology for its potential to map the brain in unprecedented ways, influencing various biological fields and opening new therapeutic avenues.
QUESTION: How might the advancements in optogenetics change the way we understand and treat neurological disorders in the future?
Medicine Nobel awarded for brain ‘switch’ that controls neurons with light: live updates
